Embecta Corp.

Embecta Corp.

EMBC·NASDAQ

$3.32

-2.8%
HealthcareDrug Manufacturers - Specialty & Generic

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

At a Glance

Live Snapshot
Market Cap$196.97M
EPS1.6400
P/E Ratio2.02
Earnings Date08/06/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Embecta Corp.

Embecta Corp. Earnings Call Transcripts

EMBC · NASDAQ